Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2025 Earnings Call Transcript March 6, 2026
Operator: Good day, and thank you for standing by. Welcome to the Evaxion Business Update and Full Year 2025 Financial Results Webcast and Conference Call. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Helen Tayton-Martin, CEO. Please go ahead.
Helen Tayton-Martin: Thank you, and good morning, everyone....
